Get started
BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)

BELLEROPHON THERAPEUTICS INC COM USD0.01(POST REV SPLIT)

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

0HMP fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0HMP does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company